Gelteq Limited (NASDAQ:GELS) Stock Short Interest Climbs 138.2%

Gelteq Limited (NASDAQ:GELS) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 520,734 shares, a growth of 138.2% from the September 15th total of 218,607 shares. Based on an average trading volume of 3,172,905 shares, the short-interest ratio is currently 0.2 days. Approximately 4.9% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Gelteq in a report on Tuesday, September 22nd. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company has an average rating of “Sell”.

Gelteq Stock Down 6.2%

GELS opened at $0.45 on Thursday. The business’s fifty day simple moving average is $0.60 and its 200 day simple moving average is $0.62. Gelteq has a 52 week low of $0.39 and a 52 week high of $2.01.

Gelteq Company Profile

Gelteq Limited is an Australian health and wellness company that develops oral delivery products using its proprietary gel-based technology. The platform is designed to deliver active ingredients in an easy-to-consume format and may be used for nutraceutical, pharmaceutical, and other health-related applications.

The company works with brand owners and other commercial partners to formulate and manufacture products such as dietary supplements, vitamins, minerals, and other functional health products.